IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BORSARI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.280
NA - Nord America 1.799
EU - Europa 1.719
SA - Sud America 405
AF - Africa 64
OC - Oceania 10
Totale 7.277
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.728
CN - Cina 1.038
SG - Singapore 1.018
IT - Italia 611
HK - Hong Kong 349
BR - Brasile 318
RU - Federazione Russa 251
VN - Vietnam 218
IN - India 189
DE - Germania 169
FR - Francia 133
BD - Bangladesh 106
SE - Svezia 101
NL - Olanda 96
KR - Corea 85
GB - Regno Unito 83
ID - Indonesia 65
FI - Finlandia 51
JP - Giappone 50
CH - Svizzera 46
AR - Argentina 33
AT - Austria 32
CA - Canada 27
TR - Turchia 27
ES - Italia 25
PL - Polonia 22
PT - Portogallo 19
UA - Ucraina 18
IE - Irlanda 17
MX - Messico 17
PH - Filippine 17
ZA - Sudafrica 17
EC - Ecuador 15
IQ - Iraq 14
PK - Pakistan 12
CO - Colombia 11
MA - Marocco 11
UZ - Uzbekistan 11
DK - Danimarca 10
TW - Taiwan 10
CI - Costa d'Avorio 9
IR - Iran 8
MY - Malesia 8
PY - Paraguay 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
BE - Belgio 7
JM - Giamaica 7
JO - Giordania 7
AZ - Azerbaigian 6
CL - Cile 6
EG - Egitto 6
TT - Trinidad e Tobago 6
DZ - Algeria 5
KE - Kenya 5
VE - Venezuela 5
CR - Costa Rica 4
NP - Nepal 4
TH - Thailandia 4
AL - Albania 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
HN - Honduras 3
HR - Croazia 3
IL - Israele 3
KZ - Kazakistan 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
UY - Uruguay 3
BB - Barbados 2
CY - Cipro 2
GH - Ghana 2
GR - Grecia 2
HU - Ungheria 2
KW - Kuwait 2
LB - Libano 2
LT - Lituania 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CD - Congo 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MW - Malawi 1
MZ - Mozambico 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 7.272
Salva come PNG Salva come JPEG
Città #
Singapore 467
Hefei 324
Hong Kong 301
Milan 237
Ashburn 213
Dallas 202
San Jose 177
Council Bluffs 165
Santa Clara 151
Bengaluru 119
Beijing 118
Los Angeles 115
Seoul 66
Hanoi 62
Moscow 61
Ho Chi Minh City 57
Lauterbourg 55
Boardman 53
Jakarta 52
New York 48
Buffalo 45
Frankfurt am Main 44
Monza 39
Guangzhou 37
Nuremberg 37
São Paulo 33
Helsinki 32
Rome 30
Tokyo 29
Munich 25
Cangzhou 23
Bologna 22
Basel 21
Shanghai 20
Dublin 19
Vienna 18
Chicago 16
Warsaw 16
Columbus 15
Washington 15
Da Nang 14
Lappeenranta 14
Amsterdam 13
Atlanta 13
Rio de Janeiro 12
Chennai 11
Hamburg 11
Paris 11
Houston 10
Romola 10
Strasbourg 10
Tashkent 10
Tianjin 10
Abidjan 9
Brooklyn 9
Chandler 9
Haiphong 9
Lisbon 9
Orem 9
Zurich 9
Dhaka 8
Johannesburg 8
Montreal 8
Shenzhen 8
Southend 8
Turin 8
West Jordan 8
Denver 7
Istanbul 7
Kuala Lumpur 7
London 7
Naples 7
Orlando 7
Phoenix 7
Pittsburgh 7
Porto 7
Salt Lake City 7
Seattle 7
Wuhan 7
Amman 6
Baghdad 6
Camden 6
Davao City 6
Fairfield 6
Groningen 6
Kent 6
Lausanne 6
Recife 6
Wilmington 6
Asunción 5
Belo Horizonte 5
Berlin 5
Biên Hòa 5
Brescia 5
Campo Grande 5
Capelle aan den IJssel 5
City of London 5
Düsseldorf 5
Guayaquil 5
Hangzhou 5
Totale 4.046
Salva come PNG Salva come JPEG
Nome #
Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents 317
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign 297
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead 280
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antiradical and antimicrobial agents 234
Role of Stereochemistry on the Biological Activity of Nature-Inspired 3-Br-Acivicin Isomers and Derivatives 223
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antimicrobial and antiradical agents 207
Chemo-enzymatic asymmetric flow synthesis of piperidine as pharmaceutically relevant scaffolds 201
Two-Step Flow Amidation of Natural Phenolic Acids as Antiradical and Antimicrobial Agents 201
Chemo-enzymatic flow synthesis of tyrosol and hydroxytyrosol carbonates and carbamates as novel antiradical and antimicrobial agents 190
Tyrosol and hydroxytyrosol carbonates and carbamates as novel antiradical and antimicrobial agents: a chemo-enzymatic flow synthesis 183
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS | [VERFAHREN ZUR IDENTIFIZIERUNG VON PI3-KINASE-ALPHA-INHIBITOREN] 151
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS 145
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 144
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα 141
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K 133
(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class i PI3K and mTOR Kinase 132
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K | [TRIAZINDERIVAT ALS REVERSIBLE UND IRREVERSIBLE KOVALENTE PI3K-HEMMER] 128
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K 124
Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond 124
Understanding Intrinsic Warhead Reactivity and Cysteine Druggability in Covalent Drug Discovery 120
Compounds having antiparasitic activity 119
4-(Difluoromethyl)-5-(4-((3 R,5 S)-3,5-dimethylmorpholino)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)pyridin-2-amine (PQR626), a Potent, Orally Available, and Brain-Penetrant mTOR Inhibitor for the Treatment of Neurological Disorders 114
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity 113
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K 112
Stereospecific Synthesis of Substituted Sulfamidates as Privileged Morpholine Building Blocks 111
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs 111
Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα 110
The Facets of Diversity: The EFMC Perspective 109
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS 107
Rapid, potent, and persistent covalent chemical probes to deconvolute PI3Kα signaling 106
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 105
Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor 103
Boosting the Impact of EFMC Young Scientists Network Through the Creation of Working Groups 100
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K | [TRIAZINDERIVAT ALS KOVALENTE INHIBITOREN VON PI3K] 100
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K 98
From Batch to Flow: Chemo-Enzymatic Asymmetric Synthesis of Piperidine Scaffolds 96
Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability 94
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange 94
Highlights from the Lowlands: Early Career Researchers Shine at Medicinal Chemistry Frontiers 2024 91
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class i PI3K/mTOR Inhibitor as Clinical Candidate in Oncology 86
Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology 80
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 80
Chemical and Structural Strategies to Selectively Target mTOR Kinase 80
Disease related mutations in PI3Kgamma disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors 80
A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR Inhibitor 80
Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives 79
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity 76
Design, synthesis and antiparasitic evaluation of click phospholipids 76
Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders 74
Two-drug trick to target the brain blocks toxicity in the body 74
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 74
Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic Infections 73
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti- Trypanosoma brucei Agent 73
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 71
Targeting Phosphoinositide 3-Kinase – Five Decades of Chemical Space Exploration 71
Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics 69
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors 66
Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety 62
Development of First-in-Class Covalent Inhibitors of PFKFB3 for PDAC treatment 60
Scalable, Economical, and Practical Synthesis of 4-(Difluoromethyl)pyridin-2-amine, a Key Intermediate for Lipid Kinase Inhibitors 57
Excited-state intramolecular proton transfer in a bioactive flavonoid provides fluorescence observables for recognizing its engagement with target proteins 56
Target-based approaches for the discovery of new antimycobacterial drugs 56
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 55
From pan-active to parasite-selective antiparasitic agents: A scaffold hopping approach 52
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange 52
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 51
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 50
Fifteen Years, One Mission: Innovative, Inspirational, and Impactful Discoveries 33
null 20
Chemo-enzymatic flow synthesis of chiral piperidine scaffolds 5
In This Issue 3
Announcing the Early Career Board of Journal of Medicinal Chemistry 3
In This Issue 3
Announcing the Early Career Board of ACS Medicinal Chemistry Letters 3
Totale 7.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 8 0
2021/202239 2 2 4 8 5 0 3 2 2 0 7 4
2022/202364 4 3 2 3 3 7 4 2 5 1 25 5
2023/2024814 3 7 5 44 181 107 84 20 59 81 104 119
2024/20252.178 93 158 60 121 212 94 119 250 128 205 202 536
2025/20264.498 426 581 625 500 322 241 458 220 453 289 383 0
Totale 7.651